Therapeutic potential of selective serotonin reuptake inhibitor and anti-inflammatory COX-2 inhibitors drugs for epilepsy
DOI:
https://doi.org/10.33448/rsd-v11i8.31319Keywords:
Epilepsy; Anti-inflammatory; SSRI; Serotonin; Kynurenine.Abstract
Epilepsy is a neurological disease caused by disturbances in the electrical propagation between neurons, which causes great damage to patients' lives, and can even lead to death. There are several proposals to understand its biochemical functioning, so current pharmacological treatments are based on the interruption of electrical conduction or modulation of neurotransmitters, such as phenobarbital and phenytoin. Thus, the present work aims to analyze the therapeutic potential of drugs such as COX-2 inhibitors and selective serotonin reuptake inhibitors (SSRIs) in the control of epilepsy. Thus, a narrative review of the literature was carried out using the “PubMed” database in order to find the theoretical bases and experimental works that demonstrate the mechanism of such drugs. The work concludes that SSRIs and COX-2 inhibitors have several mechanisms that can theoretically treat epilepsy, this is due to the establishment of a higher concentration of the neurotransmitter serotonin, as well as a reduction in the formation of quinolinic acid, which is a potential neurotoxic agent. which contributes to epileptogenesis.
References
Afridi, R., & Suk, K. (2021). Neuroinflammatory Basis of Depression: Learning From Experimental Models. Front Cell Neurosci., 15, e691067.
Alsaegh, H., Eweis, H., Kamal, F., & Alrafiah, A. (2021). Celecoxib Decrease Seizures Susceptibility in a Rat Model of Inflammation by Inhibiting HMGB1 Translocation. Pharmaceuticals (Basel)., 14(4), 380.
Bagdy, G., Kecskemeti, V., Riba, P., & Jakus, R. (2007). Serotonin and epilepsy. J Neurochem., 100(4), 857-73.
Bombardi, C. (2012). Neuronal localization of 5-HT2A receptor immunoreactivity in the rat hippocampal region. Brain Research Bulletin, 87 (2), 259–273.
Bonnycastle, D. D., Giarman, N. J., & Paasonen, M. K. (1957). Anticonvulsant compounds and 5-hydroxy-tryptamine in rat brain. British Journal of Pharmacology and Chemotherapy, 12 (2), 228–31.
Ciranna, L. (2006) Serotonin as a Modulator of Glutamate- and GABA-Mediated Neurotransmission: Implications in Physiological Functions and in Pathology. Current Neuropharmacology, 4 (2), 101–14.
DeGiorgio, C. M., Curtis, A., Carapetian, A., Hovsepian, D., Krishnadasan, A., & Markovic, C. (2020). Why are epilepsy mortality rates rising in the United States? A population-based multiple cause-of-death study. BMJ Open., 10, e035767.
Deidda, G., Crunelli, V., & Giovanni, G. D. (2021). 5-HT/GABA interaction in epilepsy. Prog Brain Res, 259, 265-286.
Deng, N., Hu, J., Hong, Y., Ding, Y., Xiong, Y., Wu, Z., & Xie, W. (2021). Indoleamine-2,3-Dioxygenase 1 Deficiency Suppresses Seizures in Epilepsy. Front Cell Neurosci., 15, e638854.
Deurwaerdère, P. D., & Giovanni, G. D. (2020). Serotonin in Health and Disease. Int J Mol Sci., 21 (10), 3500.
Deurwaerdere, P. D., & Giovanni, G. D. (2021). 5-HT interaction with other neurotransmitters: An overview. Prog Brain Res, 259, 1-5.
Faingold, C. L., Kommajosyula, S. P., Long, X., Plath, K., & Randall, M. (2014). Serotonin and sudden death: differential effects of serotonergic drugs on seizure-induced respiratory arrest in DBA/1 mice. Epilepsy Behav, 37, 198-203.
Hernandez, J. E., Williams, P. A., & Dudek, F. E. (2002). Effects of Fluoxetine and TFMPP on Spontaneous Seizures in Rats with Pilocarpine-induced Epilepsy. Epilepsia, 43(11), 1337-1345.
Kanner, A. M. (2016). Most antidepressant drugs are safe for patients with epilepsy at therapeutic doses: A review of the evidence. Epilepsy & Behavior, 61, 282–286.
Klein, C., Patte-Mensah, C., Taleb, O., Bourguignon, J., Schmitt, M., Bihel, F., Maitre, M., & Mensah-Nyagan, A. G. (2013). The neuroprotector kynurenic acid increases neuronal cell survival through neprilysin induction. Neuropharmacology, 70, 254–260.
Kommajosyula, S. P.; & Faingold, C. L. (2019). Neural activity in the periaqueductal gray and other specific subcortical structures is enhanced when a selective serotonin reuptake inhibitor selectively prevents seizure-induced sudden death in the DBA/1 mouse model of sudden unexpected death in epilepsy. Epilepsia, 60 (6), 1221-1233.
Li, Q. H., Nakadate, K., Tanaka-Nakadate, S., Nakatsuka, D., Cui, Y., & Watanabe, Y. (2003). Unique expression patterns of 5-HT2A and 5-HT2C receptors in the rat brain during postnatal development: Western blot and immunohistochemical analyses. The Journal of Comparative Neurology, 469 (1), 128–140.
Lugo-Huitrón, R., Muñiz, P. U., Pineda, B., Pedraza-Chaverrí, J., Ríos, C., & Cruz, V. P. (2013). Quinolinic Acid: An Endogenous Neurotoxin with Multiple Targets. Oxid Med Cell Longev., 2013, e104024.
Maranhão, M.V., Gomes, E. A., & Carvalho, P. E. (2011). Epilepsia e Anestesia. Rev. Bras. Anestesiol., 61(2).
Mattson, M. P. (2019). Excitotoxicity. Handbook of Stress Series, 3, 125-134.
Merlet, I., Ryvlin, P., Costes, N., Dufournel, D., Isnard, J., Faillenot, I., Ostrowsky K., Lavenne, K., Bars, D. L., & Mauguière, F. (2004). Statistical parametric mapping of 5-HT1A receptor binding in temporal lobe epilepsy with hippocampal ictal onset on intracranial EEG. NeuroImage, 22 (2), 886–96.
Meschaks, A., Lindstrom, P., Halldin, C., Farde, L., & Savic, I. (2005). Regional Reductions in Serotonin 1A Receptor Binding in Juvenile Myoclonic Epilepsy. Archives of Neurology, 62 (6).
Oekelen, D. V., Megens, A., Meert, T., Luyten, W. H., & Leysen, J. E. (2003). Functional study of rat 5-HT2A receptors using antisense oligonucleotides. Journal of Neurochemistry, 85 (5), 1087–100.
Pereira, A. S., Shitsuka, D. M., Parreira, F. J., & Shitsuka, R. (2018). Methodology of scientific research. [e-Book]. Santa Maria City. UAB / NTE / UFSM Editors. Accessed on: May, 1st, 2022. Available https://repositorio.ufsm.br/bitstream/handle/1/15824/Lic_Computacao_Metodologia-Pesquisa-Cientifica.pdf?sequence=1
Przegalinski, E., Baran, L., & Siwanowicz, J. (1994). Role of 5-Hydroxytryptamine Receptor Subtypes in the 1-[3-(Trifluoromethyl)Phenyl] Piperazine-Induced Increase in Threshold for Maximal Electroconvulsions in Mice. Epilepsia, 35 (4), 889–894.
Rodríguez, J. J., Noristani, H. N., Hoover, W. B., Linley, S. B., & Vertes, R. P. (2011). Serotonergic projections and serotonin receptor expression in the reticular nucleus of the thalamus in the rat. Synapse, 65 (9), 919–28.
Santana, N. (2004). Expression of Serotonin1A and Serotonin2A Receptors in Pyramidal and GABAergic Neurons of the Rat Prefrontal Cortex. Cerebral Cortex, 14 (10), 1100–1009.
Shneker, B. F., & Fountain, N. B. (2003). Epilepsy. Dis Mon, 49 (7), 426-478.
Sills, G. J., & Rogawski, M. A. (2020). Mechanisms of action of currently used antiseizure drugs. Neuropharmacology, 168, e107966.
Silva, A. V., & Cabral, F. R. (2008). Ictogenesis, epileptogenesis and mechanism of action of the drugs used for prevent and treat epilepsy. J. epilepsy clin. neurophysiol., 14 (2).
Singh, T., & Goel, R. K. (2017). Managing epilepsy-associated depression: Serotonin enhancers or serotonin producers?. Epilepsy & Behavior, 66, 93–99.
Song, T., Li, D., Huang, S., Yang, L., Wang, X., Jiang, Y., & Liu, Y. (2016).Effects of cyclooxygenase-2 selective inhibitor celecoxib on the expression of major vault protein in rats with status epilepticus. Chinese Journal of Contemporary Pediatrics, 18(5), 440–445.
Southam, E., Kirkby, D., Higgins, G. A., & Hagan, R. M. (1998). Lamotrigine inhibits monoamine uptake in vitro and modulates 5-hydroxytryptamine uptake in rats. European Journal of Pharmacology, 358 (1), 19–24.
Stean, T. O., Atkins, A. R., Heidbreder, C. A., Quinn, L. P., Trail, B. K., & Upton, N. (2005). Postsynaptic 5-HT1B receptors modulate electroshock-induced generalised seizures in rats. British Journal of Pharmacology, 144 (5), 628–635.
Tupal, S., & Faingold, C. L. (2019). Fenfluramine, a serotonin-releasing drug, prevents seizure-induced respiratory arrest and is anticonvulsant in the DBA/1 mouse model of SUDEP. Epilepsia, 60 (3), 485-494.
Wang, R., & Reddy, P. H. (2018). Role of glutamate and NMDA receptors in Alzheimer’s disease. J Alzheimers Dis., 57(4), 1041–1048.
World Health Organization (WHO). (2022). Epilepsy. https://www.who.int/news-room/fact-sheets/detail/epilepsy#
Yan, Q. S., Jobe, P. C., & Dailey, J. W. (1994). Evidence that a serotonergic mechanism is involved in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats. European Journal of Pharmacology, 252 (1), 105–112.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Matheus dos Santos do Nascimento Carvalho; Rafael Ragazzi de Moraes; Euclides Mauricio Trindade Filho
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
